CAR-T vector products are essential tools in the field of immunotherapy. They enable efficient gene transfer to modify T cells for creating targeted cell therapies. These vectors play a crucial role in engineering CAR-T cells with enhanced specificity and therapeutic efficacy against cancers. Researchers depend on these products to optimize gene delivery systems, thereby advancing the development of adoptive cellular therapies and improving treatment outcomes in oncology.